Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
87 studies found for:    Open Studies | "Urinary Bladder, Overactive"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Study of Overactive Bladder in Women With Prolapse
Conditions: Urinary Bladder, Overactive;   Pelvic Organ Prolapse
Intervention: Other: Pre- and postoperative evaluations
2 Recruiting Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Procedure: Unilateral electrode placement and testing;   Procedure: Bilateral electrode placement and testing
3 Recruiting A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Intervention: Drug: Betmiga®
4 Recruiting This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases\Urologic Diseases
Interventions: Drug: Solifenacin Succinate;   Drug: Mirabegron;   Drug: Placebo
5 Recruiting Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Conditions: Overactive Bladder;   Lower Urinary Tract Symptoms
Interventions: Behavioral: Behavioral training;   Drug: Tolterodine + tamsulosin
6 Recruiting Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
Conditions: Overactive Bladder;   Bladder Cancer;   Synergo
Intervention: Other: Questionnaires, anticholinergic treatment, urodynamic study
7 Unknown  Grouptraining for Overactive Bladder in Adults
Condition: Overactive Bladder
Interventions: Behavioral: bladdertraining in groups;   Behavioral: bladdertraining individually
8 Recruiting Gene Expression in the Overactive Bladder in Children
Conditions: Overactive Bladder;   Children
Intervention:
9 Recruiting Therapy of the Overactive Bladder Syndrome
Condition: Overactive Bladder
Interventions: Drug: solifenacin;   Procedure: PFMT and WBVT
10 Recruiting Bladder Thermal Distention for Patients With Refractory Overactive Bladder
Condition: Overactive Bladder
Intervention: Procedure: Bladder Thermal Distention
11 Unknown  Painless Laser Therapy for Overactive Bladder
Condition: Overactive Bladder
Intervention: Device: LCT-1000TM (Manufacturer: LiteCure)
12 Recruiting Oxybutynin and Omega-3 for OAB (Overactive Bladder)
Condition: Overactive Bladder
Intervention: Drug: Omega 3 Fatty Acid
13 Not yet recruiting Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms
Condition: Overactive Bladder
Intervention: Device: Sports TENS 2
14 Unknown  Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: Solifenacin;   Drug: Oxybutynin
15 Recruiting Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive Bladder
Condition: Overactive Bladder
Intervention:
16 Unknown  Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
Conditions: Urinary Urge;   Urge Incontinence;   Overactive Bladder
Interventions: Drug: solifenacin succinate;   Drug: placebo
17 Recruiting Does Bladder Training Improve the Efficacy of Nerve Stimulation in Women With Refractory Overactive Bladders
Condition: Overactive Bladder
Interventions: Behavioral: Bladder Training (BT);   Device: Percutaneous Tibial Nerve stimulation
18 Recruiting Peripheral Electrical Stimulation for the Treatment of Overactive Bladder
Condition: Idiopathic Overactive Bladder
Intervention: Procedure: Transcutaneous Electrical Nerve Stimulation
19 Not yet recruiting Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.
Conditions: Overactive Bladder;   Benign Prostatic Hyperplasia
Interventions: Drug: Mirabegron;   Drug: Tamsulosin
20 Recruiting Post-marketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.
Condition: Overactive Bladder (OAB)
Interventions: Drug: Mirabegron tablet;   Drug: Solifenacin tablet;   Drug: Propiverine tablet;   Drug: Imidafenacin tablet;   Drug: Tolterodine capsule

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years